Aberrant expression of PDGF ligands and receptors in the tumor prone ovary of follitropin receptor knockout (FORKO) mouse

Carcinogenesis

Volumn 27, Issue 5, 2006, Pages 903-915

  Chen, Xinlei ^a   Aravindakshan, Jayaprakash ^a   Yang, Yinzhi ^a   Tiwari Pandey, Rashmi ^a   Sairam, M Ram ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; FOLLITROPIN RECEPTOR; FULVESTRANT; GONADOTROPIN; LIGAND; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM; ESTRUS CYCLE; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ESTROUS CYCLE; FEMALE; LIGANDS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; OVARY; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, FSH; SIGNAL TRANSDUCTION;

EID: 33646166433     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi305     Document Type: Article

References (51)

1. Adashi,E.Y. (1998) The IGF family and folliculogenesis. J. Reprod. Immunol., 39, 13-19.
2. Gaddy-Kurten,D., Tsuchida,K. and Vale,W. (1995) Activins and the receptor serine kinase superfamily. Recent Prog. Horm. Res., 50, 109-129.
3. Lamm,M.L., Rajagopalan-Gupta,R.M. and Hunzicker-Dunn,M. (1999) Epidermal growth factor-induced heterologous desensitization of the luteinizing hormone/choriogonadotropin receptor in a cell-free membrane preparation is associated with the tyrosine phosphorylation of the epidermal growth factor receptor. Endocrinology, 140, 29-36.
4. Jemal,A., Murray,T., Ward,E., Samuels,A., Tiwari,R.C., Ghafoor,A., Feuer,E.J. and Thun,M.J. (2005) Cancer statistics, 2005. CA Cancer J.Clin., 55, 10-30.
5. Fredriksson,L., Li,H. and Eriksson,U. (2004) The PDGF family: Four gene products form five dimeric isoforms. Cytokine Growth Factor Rev., 15, 197-204.
6. Heldin,C.H. and Westermark,B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev., 79, 1283-1316.
7. Hoch,R.V. and Soriano,P. (2003) Roles of PDGF in animal development. Development, 130, 4769-4784.
8. Tallquist,M. and Kazlauskas,A. (2004) PDGF signaling in cells and mice. Cytokine Growth Factor Rev., 15, 205-213.
9. McWilliam,R., Leake,R.E. and Coutts,J.R. (1995) Growth factors in human ovarian follicle fluid and growth factor receptors in granulosaluteal cells. Int. J. Biol. Markers, 10, 216-220.
10. O May,J.V., Bridge,A.J., Gotcher,E.D. and Gangrade,B.K. (1992) The regulation of porcine theca cell proliferation in vitro: Synergistic actions of epidermal growth factor and platelet-derived growth factor. Endocrinology, 131, 689-697.
11. Apte,S.M., Bucana,C.D., Killion,JJ., Gershenson,D.M. and Fidler,I.J. (2004) Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecol. Oncol., 93, 78-86.
12. Apte,S.M., Fan,D., Killion,J.J. and Fidler,I.J. (2004) Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clin. Cancer Res., 10, 897-908.
13. Machida,S., Saga,Y., Takei,Y., Mizuno,I., Takayama,T., Kohno,T., Konno,R., Ohwada,M. and Suzuki,M. (2005) Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68). Int. J. Cancer, 114, 224-229.
14. Bergsten,E., Uutela,M., Li,X., Pietras,K., Ostman,A., Heldin,C.H., Alitalo,K. and Eriksson,U. (2001) PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat. Cell Biol., 3, 512-516.
15. LaRochelle,W.J., Jeffers,M., McDonald,W.F. et al. (2001) PDGF-D, a new protease-activated growth factor. Nat. Cell Biol., 3, 517-521.
16. Li,X., Ponten,A., Aase,K. et al. (2000) PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat. Cell Biol., 2, 302-309.
17. Williams,L.T. (1989) Signal transduction by the platelet-derived growth factor receptor. Science, 243, 1564-1570.
18. Auger,K.R., Serunian,L.A., Soltoff,S.P., Libby,P. and Cantley,L.C. (1989) PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell, 57, 167-175.
19. Coughlin,S.R., Escobedo,J.A. and Williams,L.T. (1989) Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science, 243, 1191-1194.
20. Kypta,R.M., Goldberg,Y., Ulug,E.T. and Courtneidge,S.A. (1990) Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell, 62, 481-492.
21. Nanberg,E. and Westermark,B. (1993) Platelet-derived growth factor increases the turnover of GTP/GDP on ras in permeabilized fibroblasts. J. Biol. Chem., 268, 18187-18194.
22. Satoh,T., Fantl,W.J., Escobedo,J.A., Williams,L.T. and Kaziro,Y. (1993) Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types. Mol. Cell. Biol., 13, 3706-3713.
23. Pengetnze, Y., Steed, M., Roby, KF., Terranova, PF. and Taylor, CC. (2003) Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell fine. Biochem. Biophys. Res. Commun., 309: 377-383,
24. Aittomaki,K., Lucena,J.L., Pakarinen,P. et al. (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell, 82, 959-968.
25. Balla,A., Danilovich,N., Yang,Y. and Sairam,M.R. (2003) Dynamics of ovarian development in the FORKO immature mouse: Structural and functional implications for ovarian reserve. Biol. Reprod., 69, 1281-1293.
26. Dierich,A., Sairam,M.R., Monaco,L., Fimia,G.M., Gansmuller,A., LeMeur,M., and Sassone-Corsi,P. (1998) Impairing follicle-stimulating hormone (FSH) signaling in vivo: Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl Acad. Sci. USA, 95, 13612-13617.
27. Kumar,T.R., Wang,Y., Lu,N, and Matzuk,M.M. (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet., 15, 201-204.
28. Tapanainen,J.S., Aittomaki,K., Min,J., Vaskivuo,T. and Huhtaniemi,I.T. (1997) Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat. Genet., 15, 205-206.
29. Savolainen-Peltonen,H., Loubtchenkov,M., Petrov,L., Delafontaine,P. and Hayry,P. (2004) Estrogen regulates insulin-like growth factor 1, platelet-derived growth factor A and B, and their receptors in the vascular wall. Transplantation, 77, 35-42.
30. Aravindakshan, J.P., Chen, XinLei, Yang, Y. and Sairam, M.R. (2005) Microarray analysis of ovarian gene expression in FORKO mice: Insights into the mechanism of follitropin receptor signalling. Biol. Reprod., 73(suppl. 1), M481.
31. Danilovich,N., Roy,I. and Sairam,M.R. (2001) Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology, 142, 3673-3684.
32. Chen, XinLei, Aravindakshan, J.P., Yang, Y. and Sairam, M.R. (2005). Alteration in ovarian surface epithelium and age dependent propensity for ovarian tumors in FSH receptor (FORKO) female mice. Fertility Sterility 84(suppl. 1), S61.
33. Danilovich,N., Babu,P.S., Xing,W., Gerdes,M., Krishnamurthy,H. and Sairam,M.R. (2000) Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology, 141, 4295-4308.
34. Cox,O.T., Simpson,D.A., Stitt,A.W. and Gardiner,T.A. (2003) Sources of PDGF expression in murine retina and the effect of short-term diabetes. Mol. Vis., 9, 665-672.
35. Fathalla,M.F. (1971) Incessant ovulation - a factor in ovarian neoplasia? Lancet, 2, 163.
36. Boehm,K.D., Daimon,M., Gorodeski,I.G., Sheean,L.A., Utian,W.H. and Ilan,J. (1990) Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol. Reprod. Dev., 27, 93-101.
37. Dabrow,M.B., Francesco,M.R., McBrearty,F.X. and Caradonna,S. (1998) The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol. Oncol., 71, 29-37.
38. Gnessi,L., Emidi,A., Jannini,E.A., Carosa,E., MaroderM., Arizzi,M., Ulisse,S. and Spera,G. (1995) Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action. J. Cell Biol., 131, 1105-1121.
39. Gray,K., Eitzman,B., Raszmann,K., Steed,T., Geboff,A., McLachlan,J. and Bidwell,M. (1995) Coordinate regulation by diethylstilbestrol of the platelet-derived growth factor-A (PDGF-A) and -B chains and the PDGF receptor alpha- and beta-subunits in the mouse uterus and vagina: potential mediators of estrogen action. Endocrinology, 136, 2325-2340.
40. Henriksen,R., Funa,K., Wilander,E., Backstrom,T., Ridderheim,M. and Oberg,K. (1993) Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res., 53, 4550-4554.
41. Jaber,L. and Kan,F.W. (1998) Non-identical distribution pattern of epidermal growth factor and platelet-derived growth factor in the mouse uterus during the oestrous cycle and early pregnancy. Histochem. J., 30, 711-722.
42. Rodriguez-Martinez,H., Persson,E., Hurst,M. and Stanchev,P. (1992) Immunohistochemical localization of platelet-derived growth factor receptors in the porcine uterus during the oestrous cycle and pregnancy. Zentralbl. Veterinarmed. A, 39, 1-10.
43. Taylor,C.C. (2000) Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor. Endocrinology, 141, 1545-1553. 36.
44. Whiteman,D.C., Siskind,V., Purdie,D.M. and Green,A.C. (2003) Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev., 12, 42-46.
45. Risch,H.A. (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl Cancer Inst., 90, 1774-1786.
46. Okamura,Y., Myoumoto,A., Manabe,N., Tanaka,N., Okamura,H. and Fukumoto,M. (2001) Protein tyrosine kinase expression in the porcine ovary. Mol. Hum. Reprod., 7, 723-729.
47. Schmandt,R.E., Broaddus,R., Lu,K.H., Shvartsman,H., Thormon,A., Malpica,A., Sun,C., Bodurka,D.C. and Gershenson,D.M. (2003) Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer, 98, 758-764.
48. Jo,M., Gieske,M.C., Payne,C.E., Wheeler-Price,S.E., Gieske,J.B., Ignatius,I.V., Curry,T.E.Jr and Ko,C. (2004) Development and application of a rat ovarian gene expression database. Endocrinology, 145, 5384-5396.
49. Thuillier,R., Wang,Y. and Culty,M. (2003) Prenatal exposure to estrogenic compounds alters the expression pattern of platelet-derived growth factor receptors alpha and beta in neonatal rat testis: identification of gonocytes as targets of estrogen exposure. Biol. Reprod., 68, 867-880.
50. Finlay,G.A., Hunter,D.S., Walker,C.L., Paulson,K.E. and Fanburg,B.L. (2003) Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression. Am. J. Physiol. Cell Physiol., 285, C409-C418.
51. Fukuda,T., Kobayashi,T., Yasui,H., Tsutsumi,M., Konishi,Y. and Hino,O. (1999) Distribution of Tsc2 protein in various normal rat tissues and renal tumours of Tsc2 mutant (Eker) rat detected by immunohistochemistry. Virchows Arch., 434, 341-350.